Effects of metformin HCl in combination with colesevelam HCl, compared to metformin HCl alone, as initial therapy in drug naive subjects with type 2 diabetes mellitus, and the effects of colesevelam HCl on the lipid profile in subjects with pre diabetes.

Trial Profile

Effects of metformin HCl in combination with colesevelam HCl, compared to metformin HCl alone, as initial therapy in drug naive subjects with type 2 diabetes mellitus, and the effects of colesevelam HCl on the lipid profile in subjects with pre diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 26 Jun 2010 Results were presented at the 70th Scientific Sessions of the American Diabetes Association, according to a Daiichi Sankyo media release.
    • 25 Jun 2010 Results of the type 2 diabetes mellitus cohort have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA 2010).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top